Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,812 | 86 | 56.8% |
| Travel and Lodging | $1,380 | 4 | 43.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,562 | 8 | $0 (2019) |
| Novo Nordisk Inc | $310.04 | 17 | $0 (2022) |
| Lilly USA, LLC | $155.40 | 9 | $0 (2024) |
| PFIZER INC. | $145.10 | 8 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $119.44 | 7 | $0 (2021) |
| ABBVIE INC. | $116.89 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $108.68 | 3 | $0 (2018) |
| ABIOMED | $93.33 | 1 | $0 (2024) |
| Amgen Inc. | $85.69 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $64.14 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.29 | 4 | ABIOMED ($93.33) |
| 2022 | $75.95 | 4 | ABBVIE INC. ($27.54) |
| 2021 | $326.98 | 18 | Novo Nordisk Inc ($91.28) |
| 2020 | $271.13 | 16 | PFIZER INC. ($69.68) |
| 2019 | $1,864 | 22 | Edwards Lifesciences Corporation ($1,562) |
| 2018 | $369.08 | 18 | AstraZeneca Pharmaceuticals LP ($108.68) |
| 2017 | $139.42 | 8 | Astellas Pharma US Inc ($42.57) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $93.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/29/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: VIROLOGY | ||||||
| 02/23/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 02/07/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.45 | General |
| 01/19/2022 | EISAI INC. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.04 | General |
| Category: Neurology | ||||||
| 11/15/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: UROLOGY | ||||||
| 11/01/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 10/20/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/28/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Diabetes | ||||||
| 09/15/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.56 | General |
| 09/08/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/23/2021 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Neurology | ||||||
| 08/16/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: UROLOGY | ||||||
| 08/02/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Diabetes | ||||||
| 07/14/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Neuroscience | ||||||
| 05/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Diabetes | ||||||
| 05/25/2021 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $16.07 | General |
| Category: Cranial Orthotic | ||||||
| 02/03/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 01/20/2021 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Neuroscience | ||||||
| 01/19/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/04/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 146 | 191 | $48,102 | $15,595 |
| 2022 | 8 | 377 | 419 | $69,756 | $26,031 |
| 2021 | 14 | 725 | 1,449 | $209,995 | $88,349 |
| 2020 | 20 | 920 | 1,716 | $249,560 | $91,278 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 84 | $21,944 | $7,900 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 71 | $13,243 | $3,551 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,235 | $2,111 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 16 | $5,680 | $2,033 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 164 | 191 | $30,254 | $10,233 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 92 | $20,788 | $6,842 | 32.9% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 25 | 26 | $6,500 | $3,495 | 53.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $4,284 | $2,424 | 56.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $5,858 | $2,313 | 39.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 17 | $1,682 | $580.70 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 30 | $150.00 | $90.00 | 60.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 16 | 16 | $240.00 | $54.56 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 183 | 467 | $104,648 | $42,783 | 40.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 149 | 284 | $43,736 | $18,066 | 41.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 60 | $18,000 | $8,258 | 45.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 59 | 59 | $14,042 | $8,015 | 57.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $9,099 | $2,731 | 30.0% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 11 | 23 | $6,348 | $2,431 | 38.3% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2021 | 11 | 12 | $4,776 | $1,914 | 40.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 19 | 27 | $3,483 | $1,352 | 38.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 24 | $2,256 | $923.08 | 40.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 33 | 33 | $1,155 | $657.03 | 56.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 32 | 32 | $960.00 | $560.57 | 58.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 99 | 116 | $580.00 | $348.00 | 60.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 24 | 266 | $798.00 | $266.72 | 33.4% |
About Dr. Michael Oneill, MD
Dr. Michael Oneill, MD is a Family Medicine healthcare provider based in Monument, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215943808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Oneill, MD has received a total of $3,193 in payments from pharmaceutical and medical device companies, with $146.29 received in 2024. These payments were reported across 90 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,812).
As a Medicare-enrolled provider, Oneill has provided services to 2,168 Medicare beneficiaries, totaling 3,775 services with total Medicare billing of $221,254. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Monument, CO
- Active Since 08/01/2006
- Last Updated 06/19/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215943808
Products in Payments
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,562
- Ozempic (Drug) $181.70
- CHANTIX (Drug) $100.18
- Impella (Device) $93.33
- TOUJEO (Drug) $91.01
- EMGALITY (Drug) $85.17
- BEVESPI AEROSPHERE (Drug) $67.98
- Tresiba (Drug) $61.21
- ELIQUIS (Drug) $44.92
- Repatha (Biological) $44.06
- Myrbetriq (Drug) $42.57
- WELLBUTRIN (Drug) $42.53
- GEMTESA (Drug) $40.87
- FARXIGA (Drug) $40.70
- BENLYSTA (Biological) $37.21
- Victoza (Drug) $32.81
- Doc Band (Device) $31.04
- Dayvigo (Drug) $28.17
- MAVYRET (Drug) $27.54
- SYMPROIC (Drug) $23.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Monument
Dr. Dara Lowe, Md, MD
Family Medicine — Payments: $1,011
Dr. John Voth, Md, MD
Family Medicine — Payments: $606.07
Alexis Michopoulos, D.o, D.O
Family Medicine — Payments: $557.89
Dr. Melissa Devalon, Md, MD
Family Medicine — Payments: $500.25
Dr. Matthew Earl, Do, DO
Family Medicine — Payments: $457.39
Dr. Colleen Mcmanaman, Do, DO
Family Medicine — Payments: $339.95